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A B S T R A C T   
The control of antimicrobial resistance requires the development of novel antimicrobial alternatives and natu-
rally occurring peroxidase-catalyzed systems may be of great value in this era of emerging antimicrobial resis-
tance. In the peroxidase system, a peroxidase enzyme catalyzes the oxidation of a halide/pseudohalide, at the 
expense of hydrogen peroxide, to generate reactive products with broad antimicrobial properties. The appro-
priate use of peroxidase systems needs a better understanding of the identities and properties of the generated 
antimicrobial oxidants, specific targets in bacterial cells, their mode of action and the factors favoring or limiting 
their activity. Here, the ABCs (antibacterial activity, bacterial “backtalk” and cytotoxicity) of these systems and 
their mimics are discussed. Particular attention is paid to the concomitant use of thiocyanate and iodide dual 
substrates in peroxidase/peroxidase-free systems with implications on their antimicrobial activity. This review 
also provides a summary of actual applications of peroxidase systems as bio-preservatives in oral healthcare, milk 
industry, food/feed specialties and related products, mastitis and wound treatment; lastly, this review points to 
opportunities for further research and potential applications.   
1. Introduction 
Back in 1946, Alexander Fleming warned: “There is probably no 
chemotherapeutic drug to which in suitable circumstances the bacteria cannot 
react by in some way acquiring ‘fastness’ (resistance)”. Later, history has 
shown that the introduction of any novel antibiotic has been rapidly 
followed by the emergence and spread of resistance (Fig. 1). In fact, 
resistance has emerged towards every antibiotic class introduced to 
date. The antibiotic resistance crisis spurred global efforts to develop 
antibacterial alternatives. Naturally occurring peroxidase-catalyzed 
systems are among the potential candidates. In mammals, phagocytic 
cells, such as neutrophils, monocytes and eosinophils, as well as 
exocrine secretions, such as saliva and milk, contain peroxidase- 
catalyzed systems that comprise part of the host innate defense sys-
tem. In the peroxidase system, a particular peroxidase enzyme catalyzes 
the oxidation of a halide/pseudohalide, at the expense of hydrogen 
peroxide (H2O2), to generate reactive products with a wide range of 
antimicrobial activities [1]. 
Here, we review the naturally occurring peroxidase-catalyzed sys-
tems that play a role in immune defense against invading microbes, their 
mimics possessing antimicrobial activity, the importance of different 
antimicrobial oxidants, including their production, identities, mode of 
action, reported bacterial resistance mechanisms and mammalian 
cytotoxicity, as well as we highlight their use as alternative antimicro-
bials. This review intends to discuss key features of the peroxidase and 
peroxidase-mimicking antimicrobial systems to the best of the 
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knowledge available on relevant literature. 
2. Peroxidase-mediated antimicrobial systems of myeloid cells 
Myeloid cells of human blood contain peroxidases in their cyto-
plasmic granules – myeloperoxidase (MPO) in neutrophils and mono-
cytes, and eosinophil peroxidase (EPO) in eosinophils. 
2.1. Myeloperoxidase system of neutrophils 
Neutrophils are the first responders of host defense towards invading 
bacteria and fungi, and MPO is the key component of neutrophils’ 
antimicrobial armory [3]. Neutrophils are rich in MPO, which consti-
tutes approximately 5% of the total neutrophil protein and occurring in 
the cytoplasmic granules at very high concentrations, making up about 
25% of the granule proteins [4]. 
Circulating neutrophils are passive, but they can be quickly activated 
by components of opsonized bacteria, which bind to the receptors of 
neutrophils and trigger phagocytic machinery. The binding increases the 
oxygen uptake called respiratory burst and triggers the activation of 
membrane-bound nicotinamide adenine dinucleotide phosphate 
(NADPH) oxidase, which reduces molecular oxygen to superoxide 
radical (O2
•− ). O2
•− is further converted to H2O2 spontaneously or cata-
lyzed by the superoxide dismutase [5–7]. Although H2O2 can be directly 
toxic to microorganisms, its reactivity is increased many orders of 
magnitude by other mechanisms. Neutrophils employ MPO and H2O2 
(E0H2O2/H2O = 1.77 V) generated during the respiratory burst to oxidize 
preferentially chloride (Cl− ) to hypochlorous acid (HOCl) as the initial 
product. HOCl/OCl− (hypochlorite ion) equilibrium reacts with excess 
Cl− to generate chlorine (Cl2) (E0Cl2/Cl− = 1.36 V) [6]. The process of 
MPO-mediated bacterial killing of the neutrophil is illustrated in Fig. 2. 
Bacterial targets of these powerful bleaching agents include thiol groups 
(-SH), iron-sulfur centers, sulfur-ether groups, heme groups and unsat-
urated fatty acids, resulting in a loss of microbial membrane transport, 
an interruption of the membrane electron transport chain, a dissipation 
of energy reserves and a suppression of DNA synthesis because of the 
disruption of the interaction between cell membrane and the chromo-
somal origin of replication [8]. 
However, the relevance of the MPO system in the antimicrobial ar-
mory of neutrophils has been questioned because individuals with ge-
netic defects in the MPO gene do not seem to be particularly susceptible 
to life-threatening infections. This controversy was resolved by Kle-
banoff and co-authors [9] with a proposition that the MPO system will 
substantially contribute to innate host defense only when other host 
defense mechanisms are overwhelmed by the exposure to pathogens. 
In general, MPO also oxidizes iodide (I− ) (E0I2/I− = 0.54 V) and 
bromide (Br− ) (E0Br2/Br− = 1.07 V) halides, but not fluoride (F
− ) (E0F2/F−
= 2.87 V) and the pseudohalide thiocyanate (SCN− ) (E0SCN2/SCN− = 0.77 
V). Cl− is considered as the main physiological substrate for MPO 
because of its occurrence at high concentrations in plasma (100 – 140 
mM), whereas, SCN− (20 – 120 μM), Br− (20 – 100 μM) and I− (< 1 μM) 
are present in relatively low concentrations [10–12]. 
Fig. 1. Antibiotic introduction and first reported resistance. Inhibitors of: cell wall synthesis ( ), nucleic acid synthesis ( ), protein synthesis ( ) and cell 
membrane integrity ( ). Data taken from Centers for Disease Control and Prevention [2]. 
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2.2. Myeloperoxidase system of monocytes 
Monocytes share the phagocytic function of neutrophils, but they 
also play a central role in the coordination of innate and adaptive im-
munity, presenting the antigens to T lymphocytes. Monocytes eventually 
leave the bloodstream and become tissue macrophages attacking mi-
croorganisms. They function also as scavengers removing dead cell 
debris. Monocytes contain considerably less peroxidase than neutrophils 
(one-third of the peroxidase in neutrophils), and their enzyme is struc-
turally and functionally related to MPO [6,13]. 
Monocytes, like neutrophils, respond to stimulation by the respira-
tory burst, forming H2O2. MPO and H2O2 oxidize I− to form iodinating 
species (a more detailed discussion on iodinating species follows in 
section 5.2.1.), and oxidize Cl− to chlorinating agents, although in 
general, not at the same level as in neutrophils [6]. When monocytes 
transform into macrophages they lose their granule MPO and do not 
utilize MPO/H2O2-dependent antimicrobial mechanism [3,6]. 
2.3. Eosinophil peroxidase system of eosinophils 
Eosinophils are important in allergic reactions and host defense 
against parasites [3]. Eosinophils, while activated, release EPO, and 
similar to MPO, use NADPH oxidase-derived H2O2 to oxidize preferen-
tially Br− and generate a brominating agent hypobromous acid (HOBr) 
[14]. EPO can also oxidize I− and SCN− , as well as Cl− at acidic pH [15]. 
3. Peroxidase-mediated antimicrobial systems of saliva 
Human saliva contains two peroxidases, salivary peroxidase (SPO) 
and MPO. SPO is synthesized and secreted by the major salivary glands, 
whereas MPO is derived from neutrophils that enter the oral cavity 
during normal extravasation [16,17]. In stimulated whole saliva of 
healthy adults, the overall concentration of SPO and MPO ranges from 2 
to 13 μg/ml [16], the major proportion (75%) responsible for 
peroxidase-catalyzed reactions often being MPO [18]. 
The major source of H2O2 in the oral environment is a class of 
catalase-negative lactic acid bacteria, primarily Streptococci, which are 
the predominant microorganisms in the oral environment [10,19]. This 
participant of the peroxidase-catalyzed system may be generated also 
endogenously, i.e. by neutrophils in the process of phagocytosis and 
activation of oxygen metabolism [1,10]. H2O2 can also be supplied 
exogenously, by the addition of H2O2-producing systems, such as 
glucose/glucose oxidase (G/GOD), lactose oxidase and xanthine oxi-
dase, which may produce a more effective antimicrobial system than in 
the case of directly added H2O2 [1]. 
Human SPO catalyzes the oxidation of halides I− , Br− , and pseudo-
halide SCN− to respective hypo(pseudo)halites in the presence of H2O2. 
In addition, Cl− is oxidized by MPO, but not by SPO. Based on the 
relative concentrations of halides present, it was considered that Cl− was 
the leading substrate for MPO in all MPO-related antimicrobial systems 
in vivo because of its major role as a substrate for MPO in the oxidative 
killing of microbes in neutrophils [16]. However, antimicrobial studies 
showed that SCN− is more easily oxidized by MPO in saliva-like condi-
tions. Thomas and Fishman [10] investigated the oxidants produced by 
neutrophils in the presence of Cl− and SCN− . They concluded that under 
conditions similar to those of saliva, where SCN− is present at 0.1–3 mM 
and Cl− at 20 mM, hypothiocyanite (OSCN− ) was the dominant oxidant 
formed. 
4. Peroxidase-mediated antimicrobial systems of milk 
Lactoperoxidase (LPO) is an enzyme that has been found in milk from 
many mammalian species, and also in many types of secretions e.g. in 
tears, nasal fluid, airway surface fluid, uterine luminal fluid and vaginal 
secretions [20]. Human milk contains two peroxidase enzymes – LPO 
secreted from the mammary gland and MPO originated from milk leu-
kocytes. The relative amounts vary widely from sample to sample and 
depend on the stage of lactation [21]. However, our knowledge of LPO 
in human milk is limited. The properties of human LPO are similar to 
bovine milk LPO, thus, surrogate bovine LPO has been generally used to 
study peroxidase-derived antimicrobial properties of milk. In bovine 
milk, LPO is, parallel to xanthine oxidase, the most abundant enzyme. Its 
concentration is approximately 30 mg/l, constituting about 0.5% of the 
whey proteins [1]. 
The primary role of the LPO system is to protect the lactating 
mammary gland and the intestinal tract of the newborn infants against 
invading bacteria, fungi and viruses [22]. A recent review provides a 
detailed, up-to-date summary of studies exploring the antibacterial, 
antifungal, antiviral and antiparasitic properties of LPO systems [23]. 
LPO preferentially catalyzes the oxidation of SCN− , but also I− and 
Br− [24]. Another component of the LPO system, hydrogen peroxide, is 
not normally detected in raw milk. Many milk bacteria, Lactococci, 
Lactobacilli and Streptococci can produce sufficient H2O2 under aerobic 
conditions. The source of H2O2, as in the oral environment, can be 
endogenous by leukocytes in the process of phagocytosis, as well as, 
exogenous by the addition of H2O2-generating systems, such as G/GOD, 
sodium percarbonate, etc. [15]. 
The thiocyanate anion is another major component of the LPO sys-
tem. It is secreted from mammary, salivary, lacrimal and gastric glands. 
Its concentration is partly dependent on the eating and smoking habits of 
a human. In human milk, it has been reported that average values range 
from 0.1 to 4 µM [25]. The major source of SCN− is the detoxification 
reaction of cyanide (CN− ) by the enzyme thiosulfate cyanide sulfur-
transferase, which primarily occurs in the liver. Also, certain vegetables 
from Brassica cruciferae (cauliflower, cabbage, kale, etc.) contain a 
notable amount of thiocyanate precursors, such as the glucosinolates, 
which upon hydrolysis produce SCN− , and/or isothiocyanate and ni-
triles [1,21]. 
5. Mechanism of halide oxidation 
The layout of reactions generating enzyme intermediates is illus-
trated in Fig. 3 [1,3,12,26–28]. Halide oxidation starts with the reaction 
of peroxidase with H2O2. The active site of the native peroxidase enzyme 
Fig. 2. Neutrophil killing of bacteria mediated by the myeloperoxidase (MPO) 
system. The bacterium is opsonized and thus recognized by a neutrophil. The 
pathogen is then engulfed (phagocytosis), triggering the respiratory burst, and 
killed within the phagosome by the bleaching agents formed via the “toxic 
triad” (MPO/H2O2/Cl− ). 
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contains a ferric heme, which is oxidized with H2O2 to form compound I 
(Reaction (1)). Compound I is an oxoiron(IV) intermediate [Fe(IV) = O] 
containing a porphyrin π-cation radical (+̇Por) [29]. Compound I is 
converted back to the native enzyme through direct two-electron 
reduction of a (pseudo)halide (X− ) generating (pseudo)hypohalous 
acid (HOX) (halogenation cycle; Reaction (2)). Alternatively, compound 
I can oxidize a range of reducing substrates (AH2) by a mechanism 
involving two sequential single-electron steps. The first step leads to the 
generation of a second enzyme intermediate, compound II, which is 
subsequently reduced to the native enzyme by a second molecule of 
reducing AH2 substrate, releasing free radicals (AH
•) (peroxidase cycle; 
Reactions (3), (4)). Phenolic acids, aromatic phenols, indoles, amines 
and sulfonates are typical reducing substrates [30]. It is considered that 
compound II is inactive in (pseudo)halide oxidation [12], thus the agent 
that oxidizes the (pseudo)halide is compound I. 
Although the catalytic mechanisms of different peroxidases are 
similar, they are different in their ability, or inability, to oxidize various 
(pseudo)halides. Compound I oxidizes halides at different rates (I− >
Br− > Cl− ); however, compound I of different peroxidases may have 
different redox potential. Thus, although all peroxidases will catalyze 
the oxidation of I− , at neutral pH, only MPO will oxidize Cl− , while EPO 
will oxidize it only at acidic pH and SPO and LPO will not, and none of 
these enzymes is capable of oxidizing F− . The pseudohalide SCN− will be 
oxidized also by LPO, MPO, EPO and SPO [31,32]. 
5.1. Oxidants generated by the oxidation of thiocyanate with MPO, EPO 
and LPO, their antibacterial mechanism of action, bacterial resistance and 
mammalian cytotoxicity (summarized in Table 1) 
5.1.1. Peroxidase oxidation of SCN−
MPO, EPO, SPO and LPO are all able to convert SCN− into products 
with antibacterial activities. In particular, the chemistry of SCN−
oxidation by LPO has been widely studied. The chemical species which 
are responsible for the antimicrobial activity of the LPO/H2O2/SCN−
system are assumed to be several thiocyanate oxidation products. It 
should be noted that quantitative and qualitative measurements of these 
oxidation products in biological tissues are often not available, mainly 
because adequate methods are lacking. 
The proposed mechanism for the peroxidase-catalyzed oxidation of 
SCN− is depicted in Eqs. (1)–(3) [33–36]. Oxidation can go in two 
different ways, resulting in intermediate oxidation products, which are 
responsible for the antimicrobial activity. The first pathway is oxidation 
of SCN− yielding thiocyanogen (SCN)2 (Eq. (1)), which is unstable in 
aqueous solution and rapidly hydrolyzes to hypothiocyanous acid 
(HOSCN) in equilibrium with its conjugate base OSCN− (Eqs. (2) and 
(3)). The pKa of HOSCN is 5.3, indicating that OSCN− predominates in 
most physiological fluids [25]. Alternatively, the second pathway is the 
direct production of OSCN− (Eq. (4)). Nevertheless, OSCN− is the major 
product observed over SCN− oxidation at neutral pH [35]. For ease of 
reading, within this review the terms OSCN− or HOSCN will be used 
interchangeably to represent the physiological mixture composed of 
OSCN− /HOSCN. 
However, the reaction profile is complex and depending upon reac-
tion conditions, other short-lived intermediates may be formed in 
varying amounts. Pruitt et al. [34] reported that, at neutral pH, addition 
of excess H2O2 or LPO/H2O2 to an OSCN− generated from the LPO 
system results in the formation of other highly reactive, short-lived 
antimicrobial products in addition to OSCN− , which represent higher 
oxidothiocyano derivatives, such as cyanosulfite (O2SCN− ) and cyano-
sulfate (O3SCN− ) (Eq. (5) and (6)). The authors assumed that these 
higher oxidothiocyano derivatives would have better oxidizing proper-
ties and, accordingly, would be more effective microbial inhibitors than 
OSCN− . 
H2O2 + 2SCN− + H+ ̅̅̅̅→
peroxidase
(SCN)2 + 2H2O (1)  
(SCN)2 + H2O → HOSCN + H
+ + SCN− (2)  
HOSCN ⇌ H+ + OSCN− (3) 
Fig. 3. Generation of catalytic intermediates of the peroxidase enzyme [1,3,12,26–28]. PorFe denotes the porphyrin-iron complex; X− = Cl− , Br− , I− , SCN− ; HOX =
HOCl, HOBr, HOI, HOSCN; AH2 = reducing agents. The H2O2 participant may be generated in neutrophils during respiratory burst by the membrane-bound NADPH 
oxidase. Further descriptions are given in the text. 
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H2O2 + SCN− ̅̅̅̅→
peroxidase OSCN− + H2O (4)  
OSCN− + H2O2 → O2SCN− + H2O (5)  
O2SCN− + H2O2 → O3SCN− + H2O (6) 
Chung and Wood [37] proposed that the species responsible for the 
antibacterial activity of LPO/H2O2/SCN− system may be the CN− . 
Subsequently, Modi and co-authors [38] reported that CN− can be 
formed at a ratio of [H2O2]/[SCN− ] > 2, which was confirmed by 15N 
nuclear magnetic resonance (NMR) spectroscopy and by changes in the 
optical spectrum of LPO. The authors showed that the activity of the 
system was at its maximum when [H2O2]/[SCN− ] ratio was 1 at a pH of 
6. The formation of OSCN− was also observed to be the greatest when 
the ratio of [H2O2]/[SCN− ] was 1 at pH < 6. They concluded that the 
potential bactericidal or bacteriostatic activity of the LPO/H2O2/SCN−
system may be related to the formation of HOSCN/OSCN− species rather 
than CN− and (SCN)2, since these species were not present in the 
Fig. 4. Chemical structures of compounds sensitive to SCN− oxidation products. ALB = albumin; Cys = cysteine; DTT = dithiothreitol; GSC = glutathione; His =
histidine; ME = mercaptoethanol; NAD(P)H = reduced nicotinamide adenine dinucleotide (phosphate); SeCys = selenocysteine; SeMet = selenomethionine; TNB =
5-thio-2-nitrobenzoic acid; Trp = tryptophan; Tyr = tyrosine. 
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solution when the bactericidal activity of the system was maximum (i.e. 
when the [H2O2]/[SCN− ] was 1) [38]. 
5.1.2. Mechanism of action of peroxidase-oxidized SCN−
The key to the antimicrobial action of the peroxidase/H2O2/SCN−
system is the selective oxidation of sulfhydryl groups of microbial pro-
teins and other low molecular weight species of the cytoplasmic thiol 
pool. The reaction products OSCN− , HOSCN and (SCN)2 react rapidly 
with sulfhydryl groups yielding sulfenyl thiocyanate derivatives (R-S- 
SCN) (Eqs. (7)–(9)) [36]. The R-S-SCN can react with another thiol 
group to form a disulfide bond (Eq. (10)); though steric constraints may 
prevent this reaction in proteins) or can undergo further modification, 
such as reversible hydrolysis to yield sulfenic acid (Eq. (11)). 
OSCN− + R − S − H → R − S − SCN + OH− (7)  
HOSCN + R − S − H → R − S − SCN + H2O (8)  
(SCN)2 + R − S − H → R − S − SCN + SCN
− + H+ (9)  
R − S − SCN + R − S − H → R − S − S − R + SCN− + H+ (10)  
R − S − SCN + H2O ⇌ R − S − OH + SCN− + H+ (11) 
However, not all sulfhydryls are sensitive to SCN− oxidation prod-
ucts in a same level. Albumin (ALB), cysteine (Cys), dithiothreitol (DTT), 
glutathione (GSH), mercaptoethanol (ME) and 5-thio-2-nitrobenzoic 
acid (TNB) are all readily oxidized, but β-lactoglobulin is poorly 
oxidized. HOSCN, in addition to sulfur-containing species, can oxidize 
selenol-containing species (–SeH), thus, selenocysteine (SeCys), sele-
nomethionine (SeMet) residues in proteins are also targets. Under some 
conditions, such as the presence of LPO, sufficient H2O2 and SCN− , and 
when all the sulfhydryls are oxidized, modification of other targets like 
aromatic amino acid residues [tyrosine (Tyr), tryptophan (Trp) and 
histidine (His)] can also occur. While amines (–NH2) are not believed to 
be major direct targets for HOSCN, there is still evidence supporting it 
(reviewed in [39,40]). The cellular targets for HOSCN interaction are 
also reduced nicotinamide dinucleotides: NADH and NADPH can be 
oxidized to NAD+ and NADP+ in reversible reactions [22]. The struc-
tures of compounds oxidized by SCN− oxidation products are depicted in 
Fig. 4. 
When microbial cytoplasmic membranes are damaged by the 
oxidation of SH groups, it leads to the leakage of potassium ions, amino 
acids and polypeptides. Similarly, uptake of amino acids, purines and 
pyrimidines by the cell, and, thus, the synthesis of proteins, DNA and 
RNA are also impeded [41,42]. However, unlike oxidants like H2O2 and 
superoxide, OSCN− has not been reported to cause DNA damage [43]. 
The alteration of bacterial cell membranes and transporters also hinder 
glucose and oxygen uptake, thus inhibiting the glucose transport and 
respiration. The antimicrobial species generated by LPO-catalyzed 
oxidation of SCN− can also inhibit critical Cys in several glycolytic en-
zymes, such as hexokinase, glyceraldehyde-3-phosphate dehydrogenase 
(GADPH), aldolase and glucose-6-phosphate dehydrogenase [22]. 
Indeed, it has been hypothesized that HOSCN’s effect on bacterial 
growth is mainly glycolysis-mediated [25]. 
5.1.3. Bacterial resistance to peroxidase-oxidized SCN−
Despite the importance of the peroxidase/SCN− systems in host de-
fense against pathogens, the bacterial stress response and resistance 
mechanisms to this specific form of oxidative stress have not been 
exhaustively characterized [43]. 
Susceptibility of bacteria to antimicrobial activity of peroxidase 
systems is dependent on the state of their metabolic growth. Generally, 
growing cells are less susceptible to inhibition or killing than resting 
cells. Bacteria growing aerobically are less susceptible to the peroxidase 
systems than are those growing anaerobically [22]. 
The cell wall of Gram-positive bacteria could somewhat limit the 
accessibility but do not completely block the entrance of the peroxidase- 
oxidized SCN− products into the cell interior [22,41]. In fact, many 
studies showed that the Gram-positive and Gram-negative bacteria were 
similarly affected (summarized in [15,16]; Table 2). There is a lack of 
specific knowledge on the potential for scavenging of peroxidase- 
oxidized SCN− products in the cell wall, but in theory, low molecular 
weight species (such as GSH) and repair mechanisms of oxidized free Cys 
residues of certain proteins recently identified in the bacterial cell en-
velope (such as soluble periplasmic protein DsbG) [44] may be involved 
in the defense against these oxidants. 
The availability of H2O2 is an important factor for peroxidase- 
mediated oxidant generation, thus, bacteria which produce H2O2- 
consuming enzymes (e.g. catalase, GSH peroxidase) show low suscep-
tibility to peroxidase/SCN− -mediated inhibition [3]. 
However, bacterial resistance to LPO/SCN− -mediated killing mainly 
occurs via enzymes and substrates that inactivate and reduce the 
generated oxidizing agents, as well as by reversing the oxidation of SH 
groups [65]. Peroxidase/SCN− systems can cause both reversible and 
irreversible effects, displaying bacteriostatic and bactericidal activity. 
Several factors influence their reversible versus irreversible character. 
Irreversible inhibition is associated with long-term incubation, high 
OSCN− concentrations and particular bacterial species. Increased con-
centrations of reducing agents, such as GSH and Cys, can reverse the 
inhibition by buffering OSCN− and can ease the oxidative damage by 
reversing thiol modifications. It was shown that in E. coli cysJ was 
activated under the stress induced by LPO system [43]. CysJ together 
with CysI form the NADPH-dependent sulfite reductase, which catalyzes 
a key step in the production of SH compounds such as Cys, GSH and 
coenzyme A. The authors suggested that this operon was induced to 
boost the E. coli’s own sulfhydryl production and that the activation of 
the sulfite reduction pathway was involved in the protective response 
against the LPO-mediated challenge [43]. Earlier, Mickelson and 
Anderson [66] reported that a NADPH-dependent cystine reductase may 
account for increased resistance against the LPO system in Streptococcus 
agalactiae. Another resistance mechanism was used by S. cremoris, which 
recruited NADH2 oxidase enzyme to catalyze the oxidation of HADH2 
with OSCN− by this lowering the inhibitory effect. Another bacterial 
strain, S. sanguinis had developed high expression level of NADH-OSCN 
oxidoreductase that reduced OSCN− back to SCN− [22]. 
5.1.4. Mammalian cell cytotoxicity of peroxidase-oxidized SCN−
There are numerous reports that a variety of dissimilar cells are 
subject to peroxidase-mediated toxicity. A peroxidase together with 
H2O2 and a halide (dubbed as “cytotoxic triad”) can exert toxic effects in 
vitro on bacteria, fungi, viruses, tumor cells, erythrocytes, sperm cells 
and many other mammalian cells. This non-specific toxicity of peroxi-
dase systems is not surprising, given their activity is expressed by 
hypohalous acid/hypohalite, which are small, inorganic, highly reactive 
molecules and do not have a preference for reacting with one cell type 
over the other [67]. However, long-held debate exists as to the 
mammalian cytotoxicity of peroxidase/SCN− system. This system is 
often regarded as a mild alternative to other peroxidase products, 
particularly HOCl and HOBr, based on the following characteristics: (i) 
conversion of SCN− to HOSCN by a peroxidase is viewed as a detoxifi-
cation mechanism to remove potentially more damaging oxidants, such 
as H2O2 and HOCl; (ii) its component SCN− under physiological con-
ditions is a scavenger, in particular for HOCl and HOBr; (iii) its product 
HOSCN reacts preferentially with free SH groups (e.g. free Cys) [68]. 
The literature indicates that the peroxidase/SCN− system is specif-
ically safe to mammalian cells, which are associated with the oral cavity 
and the airway. The oxidants generated from this system inhibit bacte-
ria, fungi and viruses in the oral cavity, while at the same time the 
conversion of SCN− to HOSCN limits the production of potentially tissue 
damaging oxidizing species, such as H2O2 and HOCl. Similarly, in air-
ways this system facilitates the bacterial clearance and scavenges dele-
terious oxidative species [40]. 
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However, other evidence shows that peroxidase/SCN− -derived oxi-
dants are cytotoxic to other mammalian cells like erythrocytes, macro-
phages and endothelial cells. For instance, Grisham and Ryan [17] found 
that peroxidase-generated HOSCN lysed human erythrocytes at a pH of 
6, oxidized the hemoglobin to methemoglobin, and together with 
OCSN− oxidized also the GSH. As with bacterial cells, HOSCN can target 
critical thiol proteins with high specificity also in mammalian cells. In 
another study [69], red blood cells exposed to increasing concentrations 
of EPO/H2O2/SCN− oxidation products were first depleted of GSH, after 
which GSH S-transferase, GADPH, and ATPases underwent SH 
reductant-reversible inactivation, building up the hemolysis. The oxi-
dants inactivated red blood cell membrane ATPases 10 – 1000 times 
more potently than either HOCl, HOBr and H2O2 did [69]. Similarly, 
Lloyd et al. [70] showed that HOSCN induced apoptosis and necrosis of 
macrophages (J774A.1) with greater efficacy and at lower concentra-
tions than HOCl or HOBr, due to selective targeting of critical thiol 
residues on mitochondrial membrane proteins. Love et al. [71] reported 
that the cellular targets of HOSCN in J774A.1 macrophages were mul-
tiple thiol-containing proteins involved in metabolism and glycolysis 
(fructose bisphosphate aldolase, triosephosphate isomerase, GAPDH and 
creatine kinase), together with several chaperones, antioxidants and 
structural proteins. They concluded that the ability of HOSCN to inhibit 
glycolysis and perturb energy production contributed to the cell death. 
HOSCN also induced apoptosis of human coronary artery endothelial 
cells by the increase of mitochondrial membrane permeability, the 
release of cytochrome c from the mitochondria and externalization of 
phosphatidylserine [68]. 
5.2. Oxidants generated by the oxidation of iodide with/without MPO, 
EPO and LPO, their antibacterial mechanism of action, bacterial resistance 
and mammalian cytotoxicity (summarized in Table 1) 
5.2.1. Oxidation of I−
Iodide ion too can be oxidized by MPO, SPO and LPO. I− is the most 
readily oxidizable of all halides in vitro (lower redox potential, E0I2/I− =
0.54 V), and the peroxidase-catalyzed oxidation of I− yields in molecular 
iodine (I2) and, depending on I− concentration and pH, hypoiodous acid 
(HOI), its conjugate base hypoiodite (OI− ) or other iodine species [1]. 
Few studies have suggested that I2 is the major agent, which is able to 
damage the cells [54,55,72], but HOI/OI− has also been identified as 
possessing antimicrobial properties [46–48,52]. However, the active 
agent responsible for peroxidase/I− -mediated bacterial killing is 
believed to be a mixture of iodine species that are not fully detailed due 
to the complex iodine chemistry [39]. 
Chemists earlier suggested that the reaction between I− and H2O2 
(without any peroxidase) takes place through a series of short-lived in-
termediates (such as HOI, OI− ) and observable intermediates (I2, I3− ) 
[73]. Oxidation of I− by H2O2 involves two reactions: the first one is 
slower and produces HOI (Eq. (12)) and the second one faster forms free 
iodine by the reaction of the hypoiodous acid with more iodide ion (Eq. 
(13)). The slowness of the first reaction controls the overall rate [74]. 
Triiodide anions (I3− ) also can be present in equilibrium with I− and I2 
(Eq. (14)). 
H2O2 + I− + H+ → HOI + H2O (12) 
Table 1 
Summary of the characteristics of peroxidase-catalyzed and peroxidase-mimicking antimicrobial systems. The components of the antimicrobial complexes (involving 
thiocyanate and/or iodide substrates), oxidants with reported antimicrobial activities, their cellular targets in bacteria, altered functions in cellular systems, defense/ 














Thiols (-SH; e.g. ALB, Cys, 
DTT, GSC, ME) 
Selenothiols (-SeH; e.g. Sec, 
SeMet) 
Amines (–NH2; e.g. Lys, Arg, 
His, α-amino group, N- 
terminus) 
Aromatic amino acid 
residues (e.g. Tyr, Trp, His) 
NADH, NADPH 
Alteration of cell 
membranes and 
transporters 
Inhibition of protein, 
DNA and RNA synthesis 
Inhibition of glycolysis 
Inhibition of glucose 
transport 
Inhibition of respiration 
State of metabolic growth (e.g. growing 
cells, aerobic growth) 
Cell wall of Gram-positive bacteria (less 
susceptible) 
H2O2-consuming enzymes (e.g. catalase, 
GSH peroxidase) 
Reducing agents (e.g. GSC, Cys) 
Reducing enzymes (e.g. sulfite reductase, 
















All thiols (-SH) 
Thioether moieties (R-S-R; 
e.g. Met) 
Amines (–NH2) 
Phenolic groups (–OH; e.g. 
His, Tyr) 
Imidazole groups (NH⋅⋅⋅N; e. 
g. His, Tyr) 
Aromatic amino acid 
residues (e.g. Tyr, Trp, His) 
Carbon-carbon bonds (C =
C) in unsaturated fatty acids 
NMNH 
NADH, NADPH 
C and U pyrimidine 
nucleobases 





Inhibition of protein, 
DNA and RNA synthesis 
Inhibition of glycolysis 
Inhibition of glucose 
transport 
Inhibition of respiration 
Not reported Human erythrocytes 
Human lymphoid cells 
Mouse ascetic lymphoma 
cells 













Not reported Partitioning of riboplasm 
Fragmentation of DNA 
No resistance was observed in E. coli, P. 
aeruginosa, S. aureus, multidrug-resistant 
S. aureus (MRSA) 
Human mouth epithelial cells 
Human cervical epithelial 
adenocarcinoma cells (HeLa) 
Horse erythrocytes 
ALB = albumin; Arg = arginine; C = cytosine; Cys = cysteine; DTT = dithiothreitol; GSC = glutathione; His = histidine; Lys = lysine; ME = mercaptoethanol; Met =
methionine; NAD(P)H = reduced nicotinamide adenine dinucleotide (phosphate); NMNH = reduced nicotinamide mononucleotide; Sec = selenocysteine; SeMet =
selenomethionine; TNB = 5-thio-2-nitrobenzoic acid; Trp = tryptophan; Tyr = tyrosine; U = uracil. 
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HOI + I− + H+ ⇌ I2 + H2O (13)  
I2 + I− ⇌ I3− (14) 
Gottardi [75], on the other hand, specified ten iodine species (I2, I3− , 
I5− , I62− , HOI, OI− , HI2O− , I2O− , H2OI+ and IO3− ) for the inorganic iodine- 
water system. He emphasized that the equilibria in the system are 
governed by H+ and I− , which imply that pH value and the additional 
iodide influence on species concentrations. In the most common case, 
with iodine in the presence of additional iodide at pH ≤ 6, only I2 and I3−
possess the main oxidation power. In the absence of additional iodide, at 
pH 8 – 9, HOI accounts for the major oxidation capacity. At high iodide 
concentration (e.g. Lugol’s solution), I5− and I62− species become 
important⋅H2OI+, OI− and HI2O− are prominent only at pH > 10. IO3−
has no oxidative activity in neutral and basic pH conditions, but can act 
as an oxidant in a form of HIO3 at pH < 4 [75,76]. 
5.2.2. Mechanism of action of oxidized I−
Thomas and Aune [72] have proposed that the antimicrobial activity 
of the peroxidase/H2O2/I− system is due to the oxidation of I− to I2, 
followed by rapid iodination of cell components, namely, protein sulf-
hydryls. Oxidation of cell components yields in the reduction of I2 back 
to I− , so that as a result I− is not consumed. Released I− can be re- 
oxidized and take part again in the oxidation of other protein sulfhy-
dryls. Therefore, one iodide ion can oxidize many cell components [54]. 
In such a way, I− acts as a cofactor in the transfer of oxidizing equiva-
lents from H2O2 to cell components (Fig. 5) [55]. 
Oxidation of 1 mol of R-S-H per mole of H2O2 or I2 to sulfenyl iodide 
(R-S-I) corresponds to the Eq. (15) and (16). The release of I− from R-S-I 
may occur through hydrolysis to yield a sulfenic acid derivative (Eq. 
(17)) or through disulfide formation (Eq. (18)). 
H2O2 + 2I− + 2H+ →
peroxidase
I2 + 2H2O (15)  
R − S − H + I2→R − S − I + I− + H+ (16)  
R − S − I + H2O ⇌ R − S − OH + I− + H+ (17)  
R − S − I + R − S − H→R − S − S − R + I− + H+ (18) 
Iodination and oxidation produce apparent denaturation of the 
proteins and enzymes, which are crucial for bacterial viability. The 
mode of action of oxidized iodide resembles that of thiocyanate, but 
differs in the following aspects: (i) all SH groups are oxidized by I−
oxidation products; (ii) oxidized I− species are directed against a 
broader range of molecules, such as thioether (R-S-R) and NH2 moieties 
of proteins, NADH, NADPH and reduced nicotinamide mononucleotide 
(NMNH); (iii) due to the cofactor role of I− , a greater extent of cell 
components are oxidized; (iv) cells do not recover after removal of the 
oxidized iodide. These indicate that peroxidase/I− systems have an 
irreversible bactericidal effect. 
Moreover, Gottardi [76] has indicated that, although the exact de-
tails of microbial killing by I2 or the reaction products occurring in 
inorganic aqueous solutions are not known, these oxidants have the 
following consequences: (i) oxidation of SH group of Cys amino acid 
results in failure to connect protein chains by disulfide bonds, impeding 
Table 2 
Antimicrobial spectrum of peroxidase-catalyzed and peroxidase-mimicking 
systems.  
Organism Antimicrobial system Reference 
Gram-positive bacteria 
Bacillus cereus LPO/H2O2/I− [45] 
Fusobacterium nucleatum HRPO/H2O2/I− [46] 
Micrococcus flavus LPO/I− /SCN− /G/GOD [47] 
Propionibacterium acnes LPO/I− /SCN− /G/GOD [47] 
Staphylococcus aureus LPO/I− /SCN− /G/GOD [47] 
Staphylococcus aureus LPO/H2O2/I− [45] 
Staphylococcus aureus LPO/SCN− /G/GOD, LPO/I− /SCN− / 
G/GOD 
[48] 
Staphylococcus aureus H2O2/I− /SCN− [49] 
Methicillin-resistant S. aureus H2O2/I− /SCN− [49] 
Streptococcus dysglactiae LPO/I− /GOD, LPO/SCN− /GOD [50] 
Streptococcus faecalis LPO/I− /SCN− /G/GOD [47] 
Streptococcus mutans LPO/H2O2/I− [51] 
Streptococcus mutans LPO/I− /SCN− /G/GOD [47] 
Streptococcus salivarius LPO/I− /SCN− /G/GOD [47] 
Streptococcus uberis H2O2/I− /SCN− [49] 




MPO/H2O2/I− , LPO/H2O2/I− , LPO/ 
H2O2/SCN−
[52] 
Burkholderia cepaciae LPO/I− /GOD, LPO/SCN− /GOD [50] 
Enterobacter cloacae LPO/I− /SCN− /G/GOD [47] 
Escherichia coli LPO/H2O2/SCN− [36] 
Escherichia coli LPO/H2O2/I− , LPO/H2O2/SCN− , 
LPO/H2O2/I− /SCN−
[53] 
Escherichia coli Peroxidase/H2O2/I− [54,55] 
Escherichia coli MPO/H2O2/I− , LPO/H2O2/I− , 
MPO/I− /G/GOD 
[56] 
Escherichia coli H2O2/I− /SCN− [49,57] 
Escherichia coli LPO/I− /SCN− /G/GOD [47] 
Escherichia coli LPO/SCN− /G/GOD, LPO/I− /SCN− / 
G/GOD 
[48] 
Escherichia coli LPO/I− /GOD, LPO/SCN− /GOD [50] 
Flexibacter psychrophilus LPO/I− /SCN− /G/GOD [58] 
Fusobacterium nucleatum MPO/H2O2/I− [51] 
Klebsiella aerogenes LPO/I− /SCN− /G/GOD [47] 
Porphyromonas gingivalis MPO/H2O2/I− [51] 
Proteus vulgaris LPO/I− /SCN− /G/GOD [47] 
Pseudomonas aeruginosa LPO/H2O2/I− [45] 
Pseudomonas aeruginosa H2O2/I− /SCN− [49] 
Pseudomonas aeruginosa LPO/SCN− /G/GOD, LPO/I− /SCN− / 
G/GOD 
[48] 
Pseudomonas aeruginosa LPO/I− /SCN− /G/GOD [47] 
Psuedomonas aeruginosa LPO/I− /GOD, LPO/SCN− /GOD [50] 
Pseudomonas fluorescens LPO/I− /SCN− /G/GOD [47] 
Salmonella typhimurium LPO/I− /SCN− /G/GOD [47] 
Serratia marcescens LPO/I− /SCN− /G/GOD [47]  
Fungi 
Aspergillus niger LPO/I− /SCN− /G/GOD [47] 
Botrytis cinerea LPO/H2O2/I− /SCN− [59,60] 
Candida albicans LPO/H2O2/I− /SCN− [61] 
Candida albicans LPO/I− /SCN− /G/GOD [48] 
Candida albicans LPO/I− /G/GOD [62] 
Candida albicans LPO/I− /SCN− /G/GOD [47] 
Cladosporium herbarum LPO/I− /SCN− /G/GOD [47] 
Myrothecium verrucaria LPO/I− /SCN− /G/GOD [47] 
Penicillium commune LPO/H2O2/I− /SCN− /G/GOD [63] 
Penicillium digitatum LPO/H2O2/I− /SCN− [60] 
Penicillium expansum LPO/H2O2/I− /SCN− [59,60,64] 
Penicillium funiculosum LPO/I− /SCN− /G/GOD [47] 
Penicillium italicum LPO/H2O2/I− /SCN− [60] 
Phytophthora infestans LPO/H2O2/I− /SCN− [60] 
Pityrosporum ovale LPO/I− /SCN− /G/GOD [47] 
Saccharomyces cerevisiae LPO/I− /SCN− /G/GOD [47] 
Stachybotrys atra LPO/I− /SCN− /G/GOD [47] 
Trichoderma viride LPO/I− /SCN− /G/GOD [47] 
Trichophyton interdigitale LPO/I− /SCN− /G/GOD [47] 
Trichophyton mentagrophytes LPO/I− /SCN− /G/GOD [47] 
Trichophyton rubrum LPO/I− /SCN− /G/GOD [47] 
G = glucose; GOD = glucose oxidase; LPO = lactoperoxidase; MPO =
myeloperoxidase. 
Fig. 5. The role of I− turnover in the antimicrobial action of peroxidase/H2O2/ 
I− system [54,55,72]. Red and Ox denote the reduction and oxidation reactions. 
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protein folding and synthesis; (ii) iodination of phenolic (–OH) and 
imidazole (NH⋅⋅⋅N) groups of Tyr and His amino acids, and iodination of 
cytosine (C) and uracil (U) pyrimidine nucleobases can increase the bulk 
of molecules, leading to a form of steric hindrance in hydrogen bonds; 
(iii) iodine can react with the carbon–carbon double bond (C = C) of 
unsaturated fatty acids, leading to a change in the physical properties of 
the lipids and cause membrane destabilization. 
5.2.3. Bacterial resistance to oxidized I−
Our extensive review of the literature suggests that evidence of 
resistance in bacteria to peroxidase-mediated iodide oxidants is lacking. 
Moreover, to date, there are also no reports of resistance development 
against iodine-based disinfectants. Most researchers interpret this phe-
nomenon as being due to the strong bactericidal activity, expressed by 
multiple modes of action, that include the disruption of multiple mi-
crobial metabolic pathways and destabilization of cell membrane com-
ponents, causing irreversible damage to the pathogen [77,78]. 
5.2.4. Mammalian cell cytotoxicity of peroxidase-oxidized I−
There are several reports on the cytotoxicity of peroxidase/I− sys-
tems towards normal, as well as tumor cells. It was reported that LPO, in 
the presence of H2O2 and I− , was cytotoxic for human and mouse 
lymphoid cells and human erythrocytes. This effect was rather rapid and 
highly efficient leading to 85–90% cell death within 90 min [79]. MPO 
or LPO when combined with G/GOD and I− hemolysed human eryth-
rocytes [80]. Hemolysis of this I− -dependent system was associated with 
the iodination of erythrocyte cell components (membrane proteins, 
hemoglobin). Clark et al. [81] demonstrated the cytotoxicity of I− - 
dependent system on mouse ascetic lymphoma cells using 4 cytotoxicity 
tests (51Cr release, trypan blue exclusion, inhibition of glucose C-1 
oxidation and loss of oncogenicity for mice). Stanislavski and co- 
workers [82] used antibody/glucose oxidase/lactoperoxidase conju-
gate to target murine plasmacytoma tumor cells. Cytotoxicity was 
generated when antibody/GOD/LPO targeted cells were incubated in a 
medium supplemented with glucose and sodium iodide. 
5.3. Dual (pseudo)halides in peroxidase systems and their contribution to 
the antimicrobial action 
5.3.1. Combination of Cl− and Br−
The ultimate activity of species generated by peroxidase/H2O2/ 
(pseudo)halide systems may be affected because of the reaction of the 
initial products with other (pseudo)halides. As an example, these set of 
reactions can generate trans-halogen species. More than a century ago, 
inorganic chemists proposed the existence of inter-halogens, which are 
combinations of different halogens. The general formula of most inter- 
halogen compounds is XXn− , where n = 1, 3, 5 or 7, and X is the less 
electronegative of the two halogens. Electronegativity increases moving 
upward on the halogen group: I is less electronegative than Br, followed 
by Cl and F. Both binary (BrCl, IBr, and ICl) and ternary (ICl3) inter- 
halogens have been since characterized. Anions of inter-halogens and 
poly-halides are also known; they include Cl3− , Br3− , I3− , Br2Cl− and BrCl2− . 
One pathway for their formation requires hypohalous acid (HOX) and 
halide ion (X− ), Eq. (19) [83]. 
HOX + nX− + H+ → XXn− + H2O (19) 
Employing this mechanism, HOCl can react with Br− to yield mo-
lecular bromine chloride (BrCl). Henderson et al. [83] showed that MPO 
at acidic pH via reaction of HOCl and Br− generated reactive BrCl inter- 
halogen gas that oxidized nucleobases. Whereas, Spalteholz et al. [84] 
reported a direct formation of BrCl in halide oxidation by compound I of 
MPO, but not a formation via hypohalous acids. 
5.3.2. Combination of Cl− or Br− with SCN−
Chemically, inter-halogens are extremely corrosive species that 
attack a wide range of compounds and can be implicated in mutagenesis, 
so it is critical that scavengers govern their reactive properties. One such 
potential scavenger is SCN− , an endogenous inorganic anion in human 
physiological fluids, with concentrations ranging from µM in plasma to 
mM in saliva. Ashby et al. [85] have suggested that SCN− might limit 
host tissue damage by restricting the lifetime of the more detrimental 
oxidant HOCl. They have hypothesized that SCN− acts as a redox buffer 
via the mechanism of non-enzymatic transfer of oxidizing equivalents 
from HOCl to SCN− and, thus, the oxidizing equivalents of HOCl are 
preserved in OSCN− , which is considered less lethal to mammalian cells 
(Eq. (20)). 
HOCl + SCN− → OSCN− + Cl− + H + (20) 
Likewise, Nagy et al. [86] showed that HOBr reacted rapidly with 
SCN− to yield HOSCN, and have proposed that SCN− is a highly efficient 
scavenger of HOBr, which limits the ability of HOBr to cause biological 
damage to the mammalian cells. Whether this is true remains to be 
established, as the formed HOSCN/OSCN− may be as, or more, 
damaging than HOBr or HOCl. As discussed earlier, SCN− oxidation 
species can exert considerable biological damage because they have 
greater specificity, particularly for thiols. 
5.3.3. Combination of SCN− and I−
In chemical literature, the reaction between I2 and SCN− in aqueous 
solution under normal conditions has been known for a while, which is 
characterized with production of inter-(pseudo)halogen cyanogen io-
dide (ICN): 
4I2 + SCN− + 4H2O → 7I− + 8H + + ICN + SO2−4 (21) 
On the other hand, H2O2 oxidation of iodide ion or molecular iodine 
in solutions containing SCN− was shown to generate a complex having 
the probable formula I(SCN)2− [87]. The authors suggested the reason-
able equations for those reactions as: 
H2O2 + I− + SCN− + 2H+ → I(SCN)2
−
+ 2H2O (22)  
H2O2 + I2 + 4SCN− + 2H+ → 2I(SCN)2
−
+ 2H2O (23) 
Schoneshbfer and Henglein [88] studied the transient complexes 
which could have been formed between the thiocyanate and halogen 
ions. Pulse radiolysis of aqueous solutions containing SCN− and I− under 
oxidizing conditions led to the formation of ISCN− . During the disap-
pearance of the various complexes in addition I2SCN− was formed. 
I2SCN− could be oxidized by H2O2 in the presence of excess SCN− and 
form I(SCN)2− [89]. Like the I2SCN− ion, I(SCN)2− is unstable in aqueous 
solution, but its stability is enhanced at low pH, high ionic strength and 
low temperature [89]. However, in the recent study, the 13C NMR 
spectroscopy performed on H2O2/I− /SCN− solution showed the absence 
of inter-(pseudo)halogen molecules, such as ICN, I(SCN)2− and I2SCN− , 
as well as OSCN− and I2 [59]. 
The discussed literature describes the suggested reactions and 
generated species without the involvement of a peroxidase enzyme. 
Recently, Schlorke and co-workers investigated the species formed by 
the LPO/H2O2/I− /SCN− system utilizing 13C NMR spectroscopy and gas 
chromatography-mass spectrometry (GC–MS) [90]. They identified ICN 
as a yet unknown LPO-mediated oxidation product when SCN− and an 
excess of I− (in comparison to SCN− ) were applied together. This 
product was also formed in MPO or an enzyme-free system. Further-
more, a more recent study detected I2SCN− by 13C NMR in LPO/H2O2/ 
I− /SCN− system [64]. In any case, it remains unknown as to what extent 
ICN, I2SCN− or other pointed species contribute to the antimicrobial 
activity of peroxidase-mediated systems. 
5.3.4. Mimics of naturally occurring peroxidase-catalyzed systems – 
Simultaneous incorporation of SCN− /I− dual substrates in peroxidase- 
catalyzed and/or non-catalyzed antimicrobial systems 
In general, the use of multiple drugs with different mechanisms of 
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action may affect multiple targets and multiple organisms simulta-
neously. Antibiotic combinations have been widely used to treat 
multidrug-resistant bacteria. The reasons why combination therapy is 
practiced are the following: (•) broadening antibacterial spectrum – 
ensures that at least one agent will cover the infecting pathogen; (•) 
polymicrobial infections – require more than one antibiotic to cover all 
bacterial pathogens; (•) synergy – increase the efficacy of the thera-
peutic effect, decrease the dosage while increasing/maintaining the ef-
ficacy and minimizing toxicity; (•) emergence of resistance – chances of 
emergence of resistance against two agents are lower as compared with 
a single agent [91]. Thus, incorporating two substrates (SCN− and I− ) 
simultaneously into the peroxidase and/or peroxidase-free, H2O2 and/or 
G/GOD systems, hypothetically, may generate multiple oxidants from 
both substrates, with multiple mechanisms of action, directed against 
multiple cellular targets and multiple bacterial species, with little pos-
sibility of resistance development. 
The SCN− /I− substrate couple was investigated by several researcher 
groups who reported contradictory results about the role this coupling 
played in the antimicrobial action of peroxidase-catalyzed (and/or 
enzyme-free) systems; some support antagonistic, the others synergistic 
interactions. 
(i) Antagonism of the concomitant presence of SCN− and I− in 
peroxidase systems. Klebanoff [56] observed that SCN− was inhibitory 
to the MPO/H2O2/I− system. Although he found this paradoxical, 
considering SCN− when combined with MPO and H2O2 exerted an 
antibacterial effect. 
Ihalin et al. [52] investigated the effect of both LPO and MPO sys-
tems on Actinobacillus actinomycetemcomitans with different (pseudo) 
halide substrates, SCN− , I− , Cl− and their combinations. They demon-
strated that the oxidation of I− had the highest antimicrobial ability 
followed by Cl− and SCN− . However, the addition of SCN− into either 
MPO/H2O2/Cl− or MPO (or LPO)/H2O2/I− system suppressed the 
bactericidal action of the oxidized halide. Cl− , on the other hand, did not 
affect the bactericidal effects of the MPO/H2O2/I− system, but when all 
three (pseudo)halide substrates were present, no antimicrobial effect 
was recorded. 
Subsequently, Ihalin and co-workers [51] studied the effects of I− , 
Cl− and SCN− , and their combinations, with LPO and MPO on the 
viability of Porphyromonas gingivalis, Fusobacterium nucleatum, Strepto-
coccus mutans and Streptococcus rattus. The oxidation products of I− were 
again found to be the most potent, followed by the oxidation products of 
Cl− (with MPO) and SCN− (with MPO and LPO) against all the bacteria 
tested. The effects were much weaker on the Streptococcus species. They 
reported that physiological concentrations of SCN− suppressed the ef-
fects of LPO/H2O2/I− or MPO/H2O2/I− or MPO/H2O2/Cl− systems, 
whereas, Cl− had no effect on MPO/H2O2/I− system. 
Fweja et al. [45] showed that the addition of SCN− had a negative 
effect on LPO/H2O2/I− system when tested against Staphylococcus aureus 
in a liquid medium and mixed cultures of S. aureus, Bacillus cereus and 
Pseudomonas aeruginosa inoculated in whole milk. 
Ahariz and Courtois [62] studied the susceptibility of Candida albi-
cans to LPO/G/GOD system when both SCN− and I− substrates were 
simultaneously present. They observed that LPO/I− /G/GOD reduced the 
colony-forming unit count to zero, but the addition of SCN− (0.25, 2, 3 
and 4 mM) progressively decreased this antifungal effect. Thus, their 
results also demonstrated the competition between SCN− and I− for 
peroxidase, or the scavenging effect of the SCN− . 
(ii) Synergism of the concomitant presence of SCN− and I− in 
peroxidase and/or enzyme-free systems. The incorporation of I− as an 
additional substrate for the commercial LPO/SCN− /G/GOD preserva-
tive system was carried out to broaden the antimicrobial activity of the 
system, considering OI− is effective against yeast and mold, while 
OSCN− against bacteria [47]. The authors proposed to use this antimi-
crobial system as a preservative or as an antimicrobial agent in oral 
hygiene, deodorant and antidandruff products. 
Bosch et al. [48] investigated the change in antimicrobial activity 
during storage of the peroxidase-catalyzed antimicrobial system, which 
was similar to the commercially available enzyme system described 
above [47] in that both SCN− and I− were utilized as substrates for LPO, 
and the system relied on G/GOD to generate the H2O2. The effect of I−
addition to LPO/SCN− /G/GOD system, the chemical stability and the 
change in antimicrobial effectiveness during storage were studied. The 
addition of I− with SCN− increased the fungicidal and bactericidal effect 
against C. albicans, E. coli and S. aureus confirming the synergistic action 
between I− and SCN− , with the I− /SCN− ratio of 60:10. Whereas, the 
inhibition of P. aeruginosa growth was at the same level when the system 
contained or lacked the I− . The antimicrobial stability of the LPO system 
was examined over the 18-month period. In general, the aged samples 
showed activity that was comparable to the freshly prepared solutions, 
although, with some organisms, longer contact time was needed for the 
aged system to exert the antimicrobial effect. Thus, the authors sug-
gested the use of this antimicrobial complex as a preservative in foods 
and pharmaceuticals [48]. 
In another study, Ihalin et al. [46] targeted the antimicrobial effect of 
the horseradish peroxidase (HRPO)/H2O2/I− system on F. nucleatum. 
They showed that in saliva (implying the presence of SCN− ) HRPO/ 
H2O2/I− combination reduced the number of viable bacteria to 37%, 
compared to 87% live bacteria in the saliva/HRPO/H2O2 system. These 
results suggested that saliva (SCN− ions) did not inhibit the antimicro-
bial activity of the HRPO/H2O2/I− system. 
Schlorke and co-workers [53] investigated the killing efficiency of 
the inter-(pseudo)halogen ICN oxidant generated in the LPO/H2O2/I− / 
SCN− system using the bioluminescent E. coli K12 strain that allows 
time-resolved determination of cell viability. They concluded that the 
co-presence of I− and SCN− greatly enhanced the killing activity of the 
LPO system in comparison to the sole application of I− or SCN− in the 
system. 
Bafort and co-authors showed that certain mixtures of LPO/H2O2/ 
I− /SCN− had a very good antimicrobial potential against plant patho-
gens. They tested the efficacy of the system in in vitro study against 
Phytophthora infestans, Penicillium digitatum, Penicillium italicum, Penicil-
lium expansum and Botrytis cinerea [60]. It was shown that the mixture 
containing an I− /SCN− ratio of 4.5 and diluted 3-fold inhibited pathogen 
growth by 63 – 100%. In another study, Bafort et al. [64] described that 
under precise experimental conditions (i.e. high ionic strength, an I− / 
SCN− ratio of 4.5 and acid pH of in vitro enzymatic reaction medium) an 
iodine-thiocyanate complex (I2SCN− ) was produced which inhibited the 
growth of P. expansum in vitro, a fungus responsible for various fruit 
pathologies. Later, the same group suggested using again an optimal I− / 
SCN− ratio of 4.5 to favor antimicrobial efficiency and a strongly 
mineralized medium if high doses of substrates are used. They also 
recorded that although the generated oxidants were relatively stable, 
the long-term storage of the mixture was improved at 4 ◦C [59]. The 
authors believe that this iodine-thiocyanate complex is a “green” 
biochemical method for controlling plant pathogens and is as efficient as 
conventional chemical pesticides under controlled conditions. 
Meantime, Sebaa et al. [61] used the same system implemented in 
[59,60,64] studies to verify the efficacy of iodine-thiocyanate complexes 
for Candida-colonized denture decontamination. In this study [61], the 
LPO/H2O2/I− /SCN− system was tested in vitro on the reference strain 
C. albicans and on clinical strains isolated by swabbing resin dentures. 
The dual substrate system inhibited the growth of Candida in the liquid 
medium and limited its presence in biofilms. Subsequently, an ex vivo 
clinical trial was performed to confirm the data obtained in vitro which 
showed that the mixture affected Candida carriage in 60% of the tested 
dentures after only 5 min incubation. Delightfully, the system was less 
toxic to the epithelial cells of the mouth than disinfectant chlorhexidine. 
The authors suggested that this antimicrobial system is a promising new 
strategy for the decontamination of dentures. 
The research carried out by our team was also focused on the com-
bined oxidation of I− and SCN− by H2O2, but in the absence of a 
peroxidase enzyme (H2O2/I− /SCN− antimicrobial mixture named iodo- 
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thiocyanate complex or ITC). We showed that ITC was bactericidal 
causing rapid death of not only E. coli, P. aeruginosa, S. aureus and 
multidrug-resistant S. aureus (MRSA) strains in planktonic and mono- 
species biofilm forms, but it also could eradicate dual-species biofilms 
of Streptococcus uberis and S. aureus within short 30 sec exposure time 
[49]. We observed that the bactericidal action of ITC was derived from 
the combinational effect of various antimicrobial species, such as OI− / 
OSCN− , hydroxyl radical (OḢ) and I2, the latter being the dominant 
antimicrobial component. This bactericidal effect was supposedly due to 
the simultaneous partitioning of riboplasm and fragmentation of DNA 
without visible cell rupture or lysis. In addition, our group addressed the 
emergence of bacterial resistance towards ITC and the cytotoxicity to-
wards mammalian cells. We demonstrated that the prolonged serial 
passage of E. coli, P. aeruginosa, S. aureus and MRSA in the presence of 
sub-inhibitory concentrations of ITC failed to select for resistance [49]; 
the continuous culture of E. coli under the gradually increasing selective 
pressure of ITC did not result in the development of resistance [92] and 
the ITC usage posed a low risk for resistance development via increased 
mutation rate or increased efflux [93]. To reveal the possible mechanism 
of resistance to ITC, we carried out whole-genome sequencing of the 
continuous culture of E. coli exposed to increasing ITC [92]. As no 
resistance arose despite the long-term selective pressure, we could not 
identify any determinants which could have contributed to ITC resis-
tance. From the mutation list, of interest were the mutations in DNA 
mismatch repair endonuclease MutH that, theoretically, can lead to the 
development of a mutator phenotype, thus, contributing to antimicro-
bial resistance and cross-resistance. However, another study from our 
group showed that E. coli did not develop an elevated mutation rate 
when exposed to the near-lethal concentration of ITC [93]. 
Although we observed dose-dependent cytotoxic and hemolytic ac-
tivity against human cervical epithelial adenocarcinoma HeLa cells and 
horse erythrocytes, overall the in vitro comparative cytotoxicity study of 
ITC showed that the beneficial antimicrobial properties of ITC out-
weighed its non-selective cytotoxicity [57]. Therefore, we suggest that 
the use of this antimicrobial may provide an effective and efficient 
method for killing pathogens, as well as for disinfecting and removing 
biofilm contamination without triggering resistance emergence in 
bacteria. 
6. Application of peroxidase-catalyzed systems 
As was discussed, the antimicrobial spectrum of the peroxidase- 
catalyzed and mimicking systems covers a broad range of microorgan-
isms listed in Table 2 and described in several reviews 
[15,16,22,94–96]. However, the peroxidase systems had limited appli-
cation as antimicrobial agents mostly because the enzyme purification 
from human leukocytes (MPO), human milk (LPO) or human saliva 
(SPO) is more expensive than traditional preservatives, the purification 
procedures are time-consuming, and thus, it is difficult to obtain large 
quantities of enzymes. Human MPO, LPO or SPO are purified but just for 
research objectives. Instead, LPO purified from bovine milk has been 
largely used for research and commercial reasons, as it is readily 
available and is structurally and catalytically close to human SPO and 
LPO. Additionally, recombinant peroxidases generated in wide panel of 
cell factories such as bacteria, yeast, fungus and plant have gained 
widespread applications [97]. 
LPO has found many applications thanks to its broad antimicrobial 
activity and presence in different body fluids. LPO systems are widely 
used as natural bio-preservatives in oral healthcare, milk industry, food/ 
feed specialties and cosmetics (reviewed extensively elsewhere 
[1,15,20,95,96,98]). Here, we will briefly discuss some of the various 
examples. 
6.1. Enhancement of antimicrobial activity of saliva by peroxidase system 
Commercially available oral health care products, including Biotene, 
BioXtra, Zendium Saliva, Orabarrier and Oralbalance, used LPO with or 
without its substrate SCN− to boost or restore saliva’s intrinsic antimi-
crobial ability [96]. The H2O2 component of the system was generally 
formed in situ in the mouth by a G/GOD system. Many of those com-
mercial products are available in the form of toothpaste but also 
chewing gum, mouth-rinse, moisturizing gel, lozengs, foams, etc. The 
question is, whether these products are functioning in vivo. In their 
recent review, Magacz et al. [95] compared the results of clinical trials of 
dentifrices enriched with LPO and in vitro tests of the LPO system alone 
or in combination with lactoferrin, lysozyme or immunoglobulins. The 
clinical trials involved participants from various age groups with various 
clinical conditions, e.g. malodor, xerostomia, caries and chronic peri-
odontitis, as well as healthy subjects. This review presents in details the 
results of a set of studies proving the effectiveness of the LPO system in 
the prevention and alleviation of the symptoms of mentioned oral dis-
eases, as well as the involvement of LPO system in inhibition of plank-
tonic and biofilm bacteria associated with these diseases in in vitro tests. 
Thus, we will not discuss here individual studies demonstrating the 
significance of LPO system in oral health and its efficacy in oral hygiene 
products. 
6.2. Enhancement of antimicrobial activity of milk by peroxidase system 
LPO system has an antimicrobial effect against a diversity of milk- 
borne pathogenic and spoilage bacteria. A summary of the studies, 
which targeted the influence of the LPO system on various milk-borne 
pathogens, is demonstrated in the report of the FAO/WHO technical 
meeting [94]. The foremost recommended industrial application of the 
LPO system is in the dairy industry for the preservation of raw milk 
during storage and transportation (reviewed in [15,22]). The LPO sys-
tem also has wide application in cheese production, as it can eliminate 
pathogens in the starter cultures for cheese-making and extend the shelf 
life of fresh cheese [15]. Another beneficial application of the LPO 
system is the rearing of calves. Usually, dairy calves are fed with milk 
substitutes and are prone to infections, such as enterotoxigenic E. coli. 
The addition of a preparation based on LPO system together with lac-
toferrin in the milk replacements have been shown to decrease the 
severity and duration of enteric colibacillosis in calves, even when 
calves were already infected [99]. 
6.3. Application in mastitis treatment 
The LPO system has a potential to be applied as a treatment for 
bovine mastitis. Mastitis is one of the most common diseases amongst 
dairy cows and therefore the costliest problem to the dairy industry. It is 
an inflammatory condition in the udder of mammals and occurs when 
immune cells are released into the mammary gland in response to 
invading bacteria. As a result, milk from cows with mastitis has a higher 
somatic cell count, which is reducing the yield and quality of the milk. 
Treatment regimens rely solely on antibiotic usage, but the milk treated 
with the antibiotic is not marketable. The LPO system has been sug-
gested as a potential solution to overcome this problem. 
The consensus in the literature is that the LPO system has mainly a 
bacteriostatic effect against the common udder pathogens S. agalactiae, 
S. dysgalactiae, S. uberis, E. coli, P. aeruginosa and S. aureus [94]. More-
over, even if the peroxidase system is bactericidal to mastitis pathogens 
in synthetic medium, the addition of the milk to the reaction mixture 
inhibits the bactericidal properties of the system, suggesting that milk 
proteins interfere with the bactericidal agents and form adducts with 
them [100]. It was reported that the LPO system in mastitic milk was less 
effective compared to the healthy milk because of a higher concentra-
tion of catalase enzyme and reducing agents [94]. However, a WO/ 
2012/140272 patent application [50] described a biocidal antimicrobial 
composition for use in the treatment of mastitis, which comprised of a 
peroxidase, a glycoside hydrolase (to break down disaccharide sugars 
into monosaccharides), an oxidoreductase enzyme (to react with the 
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monosaccharide sugars and release H2O2) and a substrate for peroxidase 
(dependent on which peroxidase will be used). In any case, further 
studies are required before introducing the LPO system as a suitable 
mean for in vivo treatment of bovine mastitis. 
6.4. Application in the food industry 
A large amount of the published studies have focused on the natural 
environment of LPO system (saliva, milk, etc.) and respective pathogens, 
while the antimicrobial activity of the system can also target various 
food pathogens. This led to the investigations on the application of LPO 
system for the preservation of foodstuffs, including fish, meat, fruits, 
vegetables, etc. 
Van Hooijdonk et al. [58] described a trial investigating the potential 
of the peroxidase system for use in fish farming. Their peroxidase system 
was comprised of LPO, both SCN− and I− as substrates, and G/GOD as 
the source of H2O2. They used LPO system to feed the rainbow trout fry 
and monitor the mortality during the weaning period, which is normally 
high, mainly because of infections caused by Flexibacter psychrophilus 
and Octomis salmonis. There was 30% decrease in accumulated mortality 
in the test LPO group. Elotmani and Assobhei [101] studied the com-
bined antimicrobial effects of LPO system (LPO/SCN− /G/GOD) and 
nisin against the bacterial strains isolated from sardines. They reported 
that nisin inhibited only Gram-positive bacteria, whereas LPO system 
inhibited all strains studied, and even more, the combined effect was 
significantly higher. The authors suggested that the combination of 
these two could be a possible bio-preservative for fish and fish products. 
The LPO system with both SCN− and I− substrates was successfully 
incorporated into edible films. Min and Krochta [63] showed that the 
incorporation of LPO/H2O2/SCN− /I− /G/GOD antimicrobial system into 
edible whey protein isolate (WPI) films inhibited the growth of Penicil-
lium commune and have suggested that the LPO system with WPI films 
have the potential to be used in complex food systems. A similar study 
was carried out to develop antimicrobial edible films, by combining the 
defatted soybean meal, the LPO system (LPO/H2O2/SCN− /I− /G/GOD) 
and heat pressing [102]. The authors proposed that the antimicrobial 
edible films and coatings can be applied to ready-to-eat products to 
minimize or prevent the growth of pathogenic microorganisms, 
including Salmonella, during storage. 
As discussed in section 5.3.4, Bafort and co-workers demonstrated 
that the dual I− /SCN− substrate LPO system was as efficient as a con-
ventional synthetic chemical method under well-defined conditions to 
control pests in pre and postharvest crops. They proposed that this 
alternative environment-friendly and consumer-oriented biochemical 
method can respond more adequately to the expectations of sustainable 
agriculture [59,60,64]. 
6.5. Application in wound treatment 
Wound infection can be a challenging problem, especially in the 
context of growing resistance to antibiotics. Topical application of 
peroxidase-catalyzed systems is a promising tool for wound treatment. 
Several patents were filed describing the use of peroxidase systems for 
wound healing. US 4,576,817 patent [103] proposed an organic absor-
bent material for body contact, such as a bandage and a pad, incorpo-
rating dry enzymes (oxidoreductase and, optionally, peroxidase) which 
will be activated upon contact with serum. As an oxidoreductase can be 
used GOD, generating H2O2 using the glucose from serum, and as for 
peroxidase can serve LPO, which will interact with produced H2O2 and 
an oxygen-accepting anion (SCN− , Cl− and I− ) in serum to produce 
oxidized species and inhibit bacteria. Whereas, US 7,731,954 B2 patent 
[104] proposed a wound dressing, comprised of an oxidoreductase 
enzyme and, optionally, peroxidase, wherein the enzyme(s) are present 
in hydrated condition, e.g. being present in one or more hydrogels. The 
third similar US 7,927,588 B2 patent [105] described skin dressings 
comprised of two dressings: a first dressing incorporating dry 
oxidoreductase enzyme; and a second dressing carrying a source of 
water, such that when the both are in contact water migrates from the 
second dressing towards the first and hydrates the enzyme. The first 
dressing is placed on top of the second one, and the dressings are kept 
separately before use. Alternatively, the embodiment includes also a 
peroxidase enzyme, preferably present in the hydrated condition. WO/ 
2012/140272 patent [50], mentioned in the mastitis section, also sug-
gested using their antimicrobial composition for wound treatment. In 
addition, the research conducted by our team anticipated that the ITC 
(H2O2/I− /SCN− complex) might in future find use as an antiseptic and 
disinfectant, to treat infections and/or to decontaminate surfaces and in 
particular to limit the spread and risk posed by antibiotic resistant 
bacteria [49,57,92,93]. 
7. Conclusions and areas for future work 
The antibiotic doomsday scenario is on the horizon. If we are to keep 
pace with the rise of drug resistance, we need to refill the antimicrobial 
pipeline. But there aren’t a lot of new antimicrobial drugs waiting in the 
wings to join the battle against resistant pathogens. Nature is offering a 
possible solution for this problem in a form of peroxidase-catalyzed 
systems. Peroxidase-catalyzed systems are widespread throughout na-
ture as part of mammalian innate defenses against invading microor-
ganisms. A peroxidase enzyme catalyzes the oxidation of a (psedo)halide 
substrate by hydrogen peroxide to generate highly reactive products 
with a wide range of antimicrobial properties. Over and above, the 
peroxidase-catalyzed systems are inspiring for the development of 
alternative antimicrobial therapeutics. One creative example of such 
mimics based on (pseudo)halide oxidation is the peroxidase-free – dual- 
substrate – hydrogen peroxide system which possesses even broader set 
of oxidants, targets more than one type of bacteria, has more than one 
target in a bacterial cell, thus, is not prone to trigger the emergence of 
facile resistance. 
In any case, the actual products with antimicrobial properties and 
the chemistry of their reactions depend upon the specific peroxidase/ 
peroxidase-free – substrate/substrates – oxidizer inter-relationships. A 
more detailed understanding of the oxidants that contribute most to 
lethality of peroxidase or peroxidase-like systems, modifications of mi-
crobial components and metabolism, response of microbes and detri-
mental effect towards mammalian cells remains an area for further 
study. Thus, we propose the following opportunities for future studies:  
• Expand the antimicrobial screening of peroxidase/peroxidase-like 
systems on an extended list of microorganisms, including 
multidrug-resistant clinical isolates, fungi and viruses. The general 
rule regarding antibacterial activity spectrum has been “broader is 
better”. This is true when treating severe infections, as clinicians do 
not always know the causative pathogen, and thus usage of broad- 
spectrum antimicrobial will save the precious time. 
• Scrutinize the identities of all reactive species occurring in the mix-
tures of peroxidase/peroxidase-like systems; elaborate the mecha-
nism of action studies to detect multiple targets of those multiple 
species in various types of microorganisms; link the chemical iden-
tities to their targets and antimicrobial actions. To have a fully 
characterized profile of an antimicrobial mixture one wants to know 
“who is there and what are they doing there?”  
• Seek to reduce the mammalian cytotoxicity of peroxidase/ 
peroxidase-like systems. It is well-documented that peroxidase sys-
tems (and likely peroxidase-mimicking systems) have a dual role, 
behaving as both a friend and a foe. The highlight is that as they have 
non-specific, broad-spectrum target mechanism, aside from medi-
ating bacterial cell killing, destroying invading parasites, combating 
fungal infections and inactivating viruses, they can attack a variety of 
mammalian cells, including tumor cells.  
• Investigate the therapeutic relevance of peroxidase/peroxidase-like 
systems on animal, ex vivo and in vivo models, such as wound, 
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lung, urinary tract, digestive, device-related infection models, dental 
plaque and many more. These antimicrobials have a future, but will 
they work in real life?  
• Conduct in vitro resistance studies with numerous parallel evolving 
cultures to test the dynamics and determinants of resistance towards 
peroxidase/peroxidase-like systems in drug-sensitive and/or 
multidrug-resistant pathogens; follow the cross-resistance and 
collateral sensitivity on large sets of antibiotics. If one would replay 
the tape of adaptation to these antimicrobial systems, would the 
evolution result the same outcome? 
Though the application potential of these antimicrobial systems is 
wide and is currently being explored worldwide, here as well, further 
research is needed. To our knowledge no peroxidase/peroxidase-like 
system has reached the approval as an antibacterial therapeutic so far, 
thus preclinical and clinical trials can be developed to explore their 
potential as effective pharmaceuticals, such as antimicrobial therapeu-
tics or prophylactics. Peroxidase/peroxidase-like systems may be used in 
combination therapy with bactericidal antibiotics, theoretically to re- 
sensitize the resistant bacteria towards the antibiotic and prevent the 
mutagenesis in bacteria towards antibiotics by inhibiting reactive oxy-
gen species [106]. Also, considering the peroxidase-catalyzed systems 
are the part of the innate host immunity which coexists peacefully with 
microbiota during lifetime and no resistance emerges, these systems 
may be used to help the host to restore natural microbiome by clearing 
the pathogens. Additionally, linking peroxidase/peroxidase-like systems 
with intriguing bioactivities other than antimicrobial effects will give 
more possibilities for applications and it is very likely that research in 
this ground will result in the introduction of novel mode of action and 
biological effects. For these very reasons, undoubtedly, peroxidase sys-
tems and their mimics are emerging as one of the promising nature- 
inspired antimicrobial strategies to tackle antimicrobial resistance. 
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